11th Annual Sickle Cell and Thalassemia Conference (ASCAT) in London

11th – 13th October 2017


This is the 11th consecutive opportunity to see the latest advances in diagnosis, treatment and emerging fields in haemoglobinopathies. It is an opportunity to interact on the latest advances in clinical care, transition services and emerging new therapies including updates for curative treatment options. Furthermore, you will have the opportunity to show case your work through abstracts (oral and posters) and to network with leading and cutting edge practitioners.

This year’s theme is ‘Patient choice in a changing landscape of treatment and cure for Sickle Cell and Thalassaemia’.  This will include case scenarios, expert and patient opinion, and educational sessions.  During the three days there will be sessions on genetics and genomic progress, curative therapies and emerging services.

Among the highlights we will have a book launch for ‘Sickle Cell Disease – Pain and Common Chronic Complications’ and a review of the first ten years of the Annual Scientific Conference on Sickle Cell and Thalassaemia.

The Conference is hosted by Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust.


ASCAT 2018 Steering Committee

Dr. Baba Inusa (chair), Paediatric Haematology, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust

Dr. Biree Andemariam, Associate Professor, Hematology/Oncology, Director, New England Sickle Cell Institute, Director, Connecticut Bleeding Disorders Center, University of Connecticut, USA

Dr. Andrew Campbell, Haematology,  Director,  Comprehensive Pediatric Sickle Cell Disease Program, Children’s National Medical Center, George Washington University School of Medicine, Washington, DC

Dr. Raffaella Colombatti, Azienda Ospedaliera – University of Padova, Italy

Dr. Rachel Kesse-Adu, Haematology, Guy’s and St Thomas NHS Trust

Dr. Marsha Treadwell, Northern California Network of Care for Sickle Cell Disease, UCSF Benio Children’s Hospital Oakland


DSC_5736.jpg
To a researcher with focus on thalassaemia, this was an eye opener in particular regarding the clinical reality of SCD. From emotionally intense to downright funny but always educational, this was a fantastic conference programme. I only wish I could have sat in parallel sessions!
— Carsten W. Lederer

Day 1

Parallel Sessions

Complex Issues in Adults with Sickle Cell Disease
Complex Issues in Adults with Thalassaemia
Effective Partnership with service users for advocacy
 


Very thankful and grateful for the wonderful opportunity given to be a part of 11th ASCAT 2017. Very inspired!
— A. Shifneez Shakir
DSC_5850.jpg

Day 2

Parallel Sessions

Emerging themes in Sickle Cell Disease
Education session on Thalassaemia
Approaches to Monitoring End Organ Damage within Paediatric SCD Patients
Thalassaemia – Symposium
Sleep disorders and cardiopulmonary complications in SCD
Challenges to care in Sickle Cell and Thalassemia: Assessment and intervention
Sleep disorders and cardiopulmonary complications in SCD
Challenges to care in Sickle Cell and Thalassemia: Assessment and intervention
 

Conference Dinner


Really enjoying the event as a nurse new to the speciality. Learning lots and meeting new friends and contacts.
— Anne Rutland

Day 3

Parallel sessions – Training and Nursing sessions


Haemoglobinopathy morphology and clinical case scenarios
Nursing
Global Perspectives
Educational session
Patient Perspective – Plenary Session

Debate: A cure for Sickle Cell disease or Thalassaemia Is the Priority over comprehensive care! : Yes or No!
 


Collectively we can achieve more
— Baba Inusa
DSC_5626.jpg

 

This year’s sponsors and exhibitors: